Research finds drop in number of measles cases in the EU/EEA since March 2018

During the month of July, a total of 758 cases of measles were reported across seventeen countries in the EU/EEA, which is a decrease from the 1054 cases reported during the month of June.

"Since March, the number of measles cases in the EU/EEA has dropped steadily, which is of course a positive development" says Tarik Derrough, ECDC senior expert on vaccine-preventable diseases. "However, measles continues to spread across Europe because vaccination coverage in most European countries remains sub-optimal. Only four EU/EEA countries reported figures of at least 95% vaccination coverage, for both doses of measles-containing vaccine for 2017. If the goal of eliminating measles is to be reached, vaccination coverage for children and adults needs to increase in a number of countries."

Looking at the situation over the past year (1 August 2017 to 31 July 2018), 14 118 cases of measles were reported across 30 EU/EEA Member States. The most cases were reported by Greece (3 224), Italy (2 873), France (2 794) and United Kingdom (1 724), accounting respectively for 23%, 20%, 20% and 12% of all cases reported by EU/EEA countries.

Of 14 117 cases with known age, 4 250 (30%) were children less than five years of age, while 6 115 (50%) were aged 15 years or older.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine